Repurposing of prescription medicines

4 February 2021 - The Therapeutic Goods Administration is conducting a public consultation that seeks to understand potential obstacles and ...

Read more →

The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies

18 January 2021 - Historically, Australia has been at the forefront of the application of HTA for assessing the effectiveness and ...

Read more →

Strengthening patient outcome evidence in health technology assessment: a coproduction approach

13 January 2021 - NICE worked with patients and staff from six patient organisations to review existing health technology assessment ...

Read more →

Stage 2 PBS process improvements – consultation closed

13 October 2020 - On 21 September 2020, the department hosted a webinar to provide information to industry on the ...

Read more →

Patients, users, caregivers, and citizens' involvement in local health technology assessment unit in Quebec: a survey

29 September 2020 - The aim of the survey was to provide an overview of local health technology assessment unit practices ...

Read more →

PHARMAC seeking views on widened access to juvenile idiopathic arthritis medicines

11 September 2020 - PHARMAC is looking at widening access to three funded treatments – adalimumab, etanercept and tocilizumab – to ...

Read more →

PHARMAC seeking views on new type 2 diabetes medicines

9 September 2020 - PHARMAC is looking at funding two new medicines with substantial health benefits for up to 50,000 ...

Read more →

Consultation on the Medical Services Advisory Committee revised draft guidelines

31 August 2020 - The Department of Health is interested in obtaining views and feedback from the general public and ...

Read more →

Collaborative consultation on medicines policy closes

10 July 2020 - Over the past few months, Medicines New Zealand ran an online consultation on a discussion paper produced ...

Read more →

‘Open dialogue’ needed with HTAs to improve access

25 June 2020 - Having worked in the NHS as a hospital pharmacist before moving into market access roles in ...

Read more →

Submissions received: fees and charges proposal 2020-21

23 June 2020 - On 20 January 2020, the Therapeutic Goods Administration (TGA) released on its website a consultation paper, ...

Read more →

Public Consultation - Draft 2020-21 Cost Recovery Implementation Statement for listing medicines on the PBS and designated vaccines on the NIP

20 May 2020 - As outlined in the April 2020 PBS news item – ‘Cost Recovery – Consultation Feedback’, the current ...

Read more →

Cost recovery - consultation feedback

28 April 2020 - On 12 February 2020, the Department hosted a webinar to commence broad consultation on proposed fee changes ...

Read more →

Submissions on whether the TGA should publish that a prescription medicine is under evaluation

8 April 2020 - Between 15 February and 29 March 2019, the TGA sought comments from interested parties on the ...

Read more →

Proposal to fund modified release pancreatic enzyme granules (Creon Micro)

2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...

Read more →